Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles
Year: 2020
Type: article
Abstract: -glycolic acid) (PLGA) nanoparticles with rabies virus glycoprotein (RVG29) would increase residence time and exposure of encapsulated payload to the CNS compared to non-targeted nanoparticles. Delivery kinetics and biodistribution were analyzed by administering nanoparticles loaded with the carbocyanine dye 1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindotricarbocyanine Iodide (DiR) to healthy mice. Intranasal administration yielded minimal exposure of nanoparticle payload to most peripheral organs and rapid, effective delivery to whole brain. Regional analysis of payload delivery within the CNS revealed higher delivery to tissues closest to the trigeminal nerve, including the olfactory bulb, striatum, midbrain, brainstem, and cervical spinal cord. RVG29 surface modifications presented modest targeting benefits to the striatum, midbrain, and brainstem 2 h after administration, although targeting was not observed 30 min or 6 h after administration. Payload delivery to the trigeminal nerve was 3.5× higher for targeted nanoparticles compared to control nanoparticles 2 h after nanoparticle administration. These data support a nose-to-brain mechanism of drug delivery that closely implicates the trigeminal nerve for payload delivery from nanoparticles via transport of intact nanoparticles and eventual diffusion of payload. Olfactory and CSF routes are also observed to play a role. These data advance the utility of targeted nanoparticles for nose-to-brain drug delivery of lipophilic payloads and provide mechanistic insight to engineer effective delivery vectors to treat disease in the CNS.
Source: Pharmaceutics
Authors: Eugene P. Chung(Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing), Jennifer D. Cotter(Visualization, Writing – review & editing), Alesia V. Prakapenka(Conceptualization, Data curation, Formal analysis, Funding acquisition, Writing – review & editing), Rebecca L. Cook(Conceptualization, Data curation, Writing – review & editing), Danielle M. DiPerna(Data curation), Rachael W. Sirianni(Conceptualization, Formal analysis, Funding acquisition, Writing – original draft, Writing – review & editing)
Institutions: Barrow Neurological Institute, Arizona State University
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,901
Awards: Targeting Leptomeningeal Metastasis in Medulloblastoma, Intrathecal delivery of radiation sensitizing nanoparticles in pediatric neuro-oncology, PATHOGEN-INSPIRED NANOPARTICLE DRUG DELIVERY TO MOTOR NEURONS, Graduate Research Fellowship Program (GRFP), Nanotherapeutics to alleviate neuroinflammation after TBI, Exploiting sex-dependent brain injury response for nanoparticle therapeutics
OpenAlex ID: W3001621435
